bispidinone

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Carcinoma (Carcinomatosis) 01/01/2014 - "The present study was carried out to investigate the effect of 2,4,6,8-tetraaryl-3,7-diazabicyclo[3.3.1]nonan-9-one (bispidinone) analogs on the in vitro growth of human cervical carcinoma (HeLa) cells. " 03/01/2015 - "A novel bispidinone analog induces S‑phase cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells."
2.	Pancreatic Neoplasms (Pancreatic Cancer) 01/31/2019 - "The Bispidinone Derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one Dihydrochloride Induces an Apoptosis-Mediated Cytotoxic Effect on Pancreatic Cancer Cells In Vitro."
3.	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/01/2015 - "2,4,6,8-(3)-Tetranitrophenyl-3,7-diazabicyclo[3.3.1]nonan-9-one (B16), a bispidinone analog, was synthesized to investigate its effects on cell viability, the cell cycle, and apoptotic pathways in HeLa human cervical cancer cells. "

1.	diphenyl (biphenyl)